Cidara Therapeutics (CDTX) Misses Q3 EPS by 310c

Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($3.10).

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• JPMorgan cut off lending activity for Situational Awareness - FT
• AstraZeneca's camizestrant fails primary endpoint in breast cancer trial